ストックスクリーナーアプリを入手
0.00
100.00%
-2.0301
Mural Oncology Plc (MURA) 最新ニュース
Mural Oncology shareholders approve acquisition by XRA 5 Corp. - MSN
Xoma Royalty Expands Portfolio Through Mural Oncology Acquisition - AD HOC NEWS
XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Nigeria
XOMA Royalty completes acquisition of Mural Oncology By Investing.com - Investing.com Nigeria
Xoma Completes Acquisition of Mural Oncology - TipRanks
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition - Research Tree
Xoma Royalty announces closing of transaction to acquire Mural Oncology plc - marketscreener.com
XOMA Royalty Corporation Completes Acquisition of Mural Oncology plc Under Irish High Court Sanctioned Scheme - Quiver Quantitative
Mural Oncology Plc Completes Acquisition by XRA 5 Corp. - TipRanks
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - Yahoo Finance
XOMA Royalty completes acquisition of Mural Oncology - Investing.com India
Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan
Mural Oncology plc completes acquisition by XRA 5 Corp. - MSN
Mural Oncology plc(NasdaqGM: MURA) dropped from S&P TMI Index - marketscreener.com
Mural Oncology plc (MURA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mural Oncology plc(NasdaqGM: MURA) dropped from NASDAQ Composite Index - marketscreener.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView
Mural Oncology Announces Sanction of the Scheme by the High Court - Research Tree
XOMA Royalty Corporation completed the acquisition of Mural Oncology plc from group of shareholders. - marketscreener.com
Irish court approves XOMA Royalty’s acquisition of Mural Oncology By Investing.com - Investing.com India
Irish court approves XOMA Royalty’s acquisition of Mural Oncology - Investing.com
Mural Oncology plc Announces Court Approval of Scheme for Acquisition by XOMA Royalty Corporation's Subsidiary - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) wins Irish court nod for XOMA deal, Nasdaq trading expected to end Dec. 4 - Stock Titan
Mural Oncology (MURA) Stock Analysis Report | Financials & Insights - Benzinga
Will Mural Oncology plc stock benefit from automationJuly 2025 Spike Watch & Weekly Watchlist of Top Performers - BỘ NỘI VỤ
Will Mural Oncology plc stock outperform value stocksJuly 2025 Gainers & AI Driven Stock Movement Reports - moha.gov.vn
Irish takeover panel lists three companies in offer periods By Investing.com - Investing.com Nigeria
Mural Oncology Shareholders To Receive $2.035 Cash Per Share In XOMA Royalty Acquisition - Nasdaq
Can Mural Oncology plc stock sustain revenue growth2025 Biggest Moves & Safe Entry Zone Identification - moha.gov.vn
Citadel Group discloses 1.39% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.39% stake in Mural Oncology - Investing.com India
XOMA Royalty to acquire Mural Oncology for $2.035 per share By Investing.com - Investing.com Nigeria
Mural Oncology Reports Final Consideration Payable on Closing of Acquisition by Xoma - marketscreener.com
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - The Globe and Mail
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - marketscreener.com
XOMA Royalty to acquire Mural Oncology for $2.035 per share - Investing.com
Mural Oncology plc Announces Final Determination of Additional Price Per Share in Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) to Be Acquired by XOMA Royalty for $2.035 Cash - Stock Titan
Citadel Group discloses 1.38% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.38% stake in Mural Oncology By Investing.com - Investing.com South Africa
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):